A Form 144 notice of proposed sale was filed on November 3, 2026, on behalf of David Marshall Wright, an Itron, Inc. affiliate, disclosing a planned sale of 410 shares of Itron common stock from the account of his son, Colin M. Wright.

Key Highlights

  • Proposed sale: 410 shares of Itron, Inc. common stock with an aggregate market value of $40,503.94 are proposed to be sold on approximately November 3, 2026.
  • Account holder: The securities are held in the account of Colin M. Wright, son of David M. Wright, who is identified as an officer of the company.
  • Shares outstanding: According to the filing, 43,860,429 shares of Itron common stock were outstanding at the time of the notice.
  • Acquisition source: The 410 shares to be sold were acquired through restricted stock vesting from the issuer: 315 shares on February 23, 2024, and 95 shares on February 26, 2024, both as compensation.
  • Broker: The proposed sale is to be executed through Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917.
  • Prior sales aggregated: The filing also discloses sales in the past three months by David M. Wright (58 shares on August 20, 2026; 76 shares on August 24, 2026; and 100 shares on November 2, 2026) and by two other sons, Alexander P. Wright (410 shares on November 2, 2026) and Aaron D. Wright (410 shares on November 2, 2026), whose sales are aggregated per Rule 144 requirements.

Itron Officer's Son Plans Rule 144 Common Stock Sale

The Form 144 notice was filed with respect to securities to be sold from the account of Colin M. Wright, son of David M. Wright. According to the filing, David M. Wright is an officer of Itron, Inc. (NASDAQ:ITRI), which is headquartered at 2111 N Molter Road, Liberty Lake, Washington 99019. The filing identifies David M. Wright's relationship to the issuer as forming the basis for the Rule 144 notice requirement, and the person for whose account the securities are to be sold is listed as "Wright David Marshall."

The 410 shares proposed for sale carry an aggregate market value of $40,503.94, according to the filing. The underlying securities were acquired through two restricted stock vesting events from the issuer: 315 shares vested on February 23, 2024, and 95 shares vested on February 26, 2024, both classified as compensation. The filing notes that the sale is set to take place on approximately November 3, 2026, on the NASDAQ exchange.

In the remarks section, the filing states: "Today's sale occurred in the account of Colin M. Wright, son David M. Wright, an officer of the company. There also sales in the past 3 months which occurred in the accounts of Aaron D. Wright and Alexander P. Wright, both son's of David M. Wright." Per Rule 144's aggregation requirements, the filing discloses prior three-month sales by David M. Wright totaling 234 shares across three transactions, and separate sales of 410 shares each by Alexander P. Wright and Aaron D. Wright, all on or before November 2, 2026.

What Was Disclosed

The Form 144 filing covers a proposed sale of 410 Itron common shares from the account of Colin M. Wright, son of company officer David M. Wright, with an aggregate market value of $40,503.94, and discloses related prior sales aggregated under Rule 144.